Publication | Closed Access

Leukocyte response to thymoglobulin or Atgam for induction immunosuppression in a randomized, double-blind clinical trial in renal transplant recipients

Transplant RejectionTransplantationKidney TransplantMedicineLeukocyte ResponseKidney TransplantationImmunologyHematologyDouble-blind Clinical TrialImmunosuppressive TherapyAutoimmunityRenal Transplant RecipientsImmunotherapyTransplant ImmunologyCell TransplantationNephrologyGraft Rejection